<DOC>
	<DOC>NCT03011931</DOC>
	<brief_summary>To study the correlation between simvastatin metabolism by the enterocyte and the histologic state of the intestine in treated celiac disease.</brief_summary>
	<brief_title>Simvastatin Metabolism as a Test for CD Activity (IRB 15-007568]</brief_title>
	<detailed_description>A cross sectional design incorporating subjects with active celiac disease and healed celiac disease (based on clinically-obtained biopsies); and healthy individuals.</detailed_description>
	<mesh_term>Celiac Disease</mesh_term>
	<mesh_term>Simvastatin</mesh_term>
	<criteria>1. Glutenfree diet for at least 1 year 2. Clinical endoscopy within the past month 3. Biopsies must show no villous atrophy or villous blunting 4. Villous height to crypt depth (VHCD) ratio measurement should be 2.5:1 or greater 1. 1st degree relative with Celiac Disease 2. Positive tTG IgA, already on simvastatin or statin agent 3. Unable to stop nonsteroidal or antiinflammatory drugs 4. Prior history of GI surgery other than appendectomy or cholecystectomy 5. Taking drugs know to inhibit or activate CYP3A4 6. Unable to avoid food known to inhibit CYP3A4 7. History of a reaction to statin drugs in the past 8. Pregnant or nursing women</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>